Teva Pharma Posts Lower Q4 Earnings, FY23 Outlook Within Expectations
Lilly said to be pulling Twitter ads after verification debacle | pharmaphorum
Teva Europe (@tevapharmeurope) / Twitter
Teva Europe (@tevapharmeurope) / Twitter
Teva Europe (@tevapharmeurope) / Twitter
Eli Lilly restarts 'limited' Twitter posting and advertising
Teva's migraine drug Ajovy approved in Europe | pharmaphorum
Teva Europe on Twitter: "The current work on @EU_Health's #PharmaceuticalStrategy provides a once-in-a-decade opportunity to future-proof Europe's medicine manufacturing resilience and supply chain security. #Meds4EU https://t.co/1vQOeF1Oeg" / Twitter
GSK, Pfizer lead in new global Twitter pharma influencer ranking | Fierce Pharma
Teva Europe (@tevapharmeurope) / Twitter
Teva Receives Positive Outcome for COPAXONE Label in Europe » FINCHANNEL